Affymax Stock

Affymax Enterprise Value

The Enterprise Value (EV) of Affymax (AFFY) as of Aug 12, 2026 is -5.57 M USD.

Enterprise Value

-5.57 MUSD

Last updated:

Enterprise Value (EV) of Affymax is 2026 -5.57 M USD. Enterprise Value (EV) of Affymax was 2025 - USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Affymax Stock analysis

What does Affymax do? Affymax Inc is a leading biotechnology company specializing in the development of innovative therapeutics for patients with serious diseases. The company was founded in 2001 and is headquartered in Palo Alto, California. Affymax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Affymax stock

Enterprise Value (EV) of Affymax is -5.57 M USD in 2026.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Affymax since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Affymax with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Affymax

All Key Metrics — Affymax